HUTCHMED (China) Limited (HCM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$13.43
-0.15%
Mkt Cap $2.49B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Aug 7, 2025 | $330.39M | $138.84M | -57.98% | $1.46 | $1.30 | -10.96% | — | — |
| Q3 2025 Jul 2, 2025 | — | $138.84M | — | — | $1.30 | — | — | — |
| Q1 2025 Mar 19, 2025 | $319.25M | $162.26M | -49.17% | -$0.09 | $0.03 | +137.94% | — | — |
| Q3 2024 Sep 30, 2024 | — | $162.26M | — | — | $0.03 | — | — | — |
| Q3 2024 Jul 31, 2024 | $159.67M | $152.84M | -4.28% | — | $0.01 | — | — | — |
| Q2 2024 Jun 10, 2024 | — | $152.84M | — | — | $0.07 | — | — | — |
| Q1 2024 Feb 28, 2024 | $159.24M | $152.56M | -4.19% | -$1.08 | -$0.04 | +96.32% | — | — |
| Q3 2023 Jul 31, 2023 | $153.96M | $266.44M | +73.05% | — | $0.10 | — | — | — |
| Q2 2023 Jun 20, 2023 | — | $266.44M | — | — | $0.49 | — | — | — |
| Q1 2023 Feb 28, 2023 | $105.02M | $112.18M | +6.82% | -$1.02 | -$0.12 | +88.52% | — | — |
| Q3 2022 Aug 1, 2022 | $175.22M | $202.05M | +15.31% | -$1.02 | -$0.96 | +6.00% | — | — |
| Q3 2021 Sep 30, 2021 | — | $99.38M | — | — | -$0.27 | — | — | — |
| Q3 2021 Jul 28, 2021 | $90.66M | $75.81M | -16.39% | -$0.37 | -$0.53 | -42.36% | — | — |
| Q3 2020 Sep 30, 2020 | — | $60.61M | — | — | -$0.27 | — | — | — |
| Q3 2020 Jul 30, 2020 | $94.06M | $55.20M | -41.32% | -$0.27 | -$0.24 | +9.52% | — | — |
| Q1 2020 Mar 31, 2020 | — | $51.57M | — | — | -$0.12 | — | — | — |
| Q3 2019 Sep 30, 2019 | — | $49.35M | — | — | -$0.23 | — | — | — |
| Q1 2019 Mar 31, 2019 | — | $52.17M | — | — | -$0.15 | — | — | — |
| Q3 2018 Sep 30, 2018 | — | $58.81M | — | — | -$0.19 | — | — | — |
| Q1 2018 Mar 31, 2018 | — | $52.34M | — | — | -$0.09 | — | — | — |